Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II)

ανά Kavakli, K, Yang, R, Rusen, L, Beckmann, H, Tseneklidou-Stoeter, D, Maas Enriquez, M
Τόπος έκδοσης J Thromb Haemost (2015)